ARBUTUS PROXY 2018

Company

Arbutus Biopharma Corp

Filed

April 25, 2018

Period of Report

April 23, 2018

Accession Number

0001628280-18-004972

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →